The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our series, comparing two periods: before and after 1996, when we started to apply the Milan criteria. The study population was composed of patients with a preoperative diagnosis of HCC, confirmed by the pathological report and with a survival of >1 year. Preoperative staging as revealed by radiological imagining was distinguished from postoperative data, including the variable of tumor volume. After 1996 tumor recurrences significantly decreased (6 out of 15 cases, 40% vs. 3 out of 48, 6.3%, P < .005) and 5-year patient survival improved (42% vs. 83%, P < .005). Not meeting the Milan criteria was significantly related to higher recurrence rate (37.5...
The recurrence of hepatocellular carcinoma (HCC) after transplantation is the main limitation of liv...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
The current model of liver graft allocation in place in the United States favors transplantation of ...
Milan criteria are the most frequently used limits for liver transplantation (LT) in patients...
Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver transplantation (LT),...
Ever since the initial description of the Milan criteria, used for selecting patients with hepatocel...
The Milan criteria (MC) remain the cornerstone for the selection of patients with hepatocellular can...
Background/Aim: Milan Criteria (MC) consent excellent survivals for hepatocellular carcinoma (HCC) a...
iver transplantation (LT) is accepted as the standard treatment for select patients with hepatocellu...
Hepatocellular carcinoma (HCC) is the third highest cause of cancer-related mortality, and liver tra...
The recurrence of hepatocellular carcinoma (HCC) after transplantation is the main limitation of liv...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
The current model of liver graft allocation in place in the United States favors transplantation of ...
Milan criteria are the most frequently used limits for liver transplantation (LT) in patients...
Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver transplantation (LT),...
Ever since the initial description of the Milan criteria, used for selecting patients with hepatocel...
The Milan criteria (MC) remain the cornerstone for the selection of patients with hepatocellular can...
Background/Aim: Milan Criteria (MC) consent excellent survivals for hepatocellular carcinoma (HCC) a...
iver transplantation (LT) is accepted as the standard treatment for select patients with hepatocellu...
Hepatocellular carcinoma (HCC) is the third highest cause of cancer-related mortality, and liver tra...
The recurrence of hepatocellular carcinoma (HCC) after transplantation is the main limitation of liv...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...
BACKGROUND: Selection criteria for patients with hepatocellular carcinoma (HCC) suitable for liver t...